Functioning Pituitary Adenoma with Xanthogranulomatous Features: Review of Literature and Case Report

Abstract

Objectives We present a patient with a prolactin-secreting adenoma with extensive secondary, noninfectious, xanthogranulomatous changes due to remote intratumoral bleeding and provide a literature review of xanthogranulomas (XGs) of the sellar region with emphasis on prolactinomas with xanthogranulomatous features.

Design Case report, with PubMed search of cases of sellar XG, focusing on neuroimaging and surgical approach.

Results A 35-year-old male was found to have a large sellar/suprasellar calcified/cystic mass. Endoscopic transsphenoidal approach for extradural resection was performed and diagnosis made. Review generated 31 patients with the diagnosis of sellar XG. In a minority (6 patients), the underlying lesion for the XG was a pituitary adenoma. Headache was the most common presenting symptom and panhypopituitarism the most common endocrinological abnormality. Examples of hyperprolactinemia associated with sellar XG are also uncommon and due to stalk effect. Neuroimaging of XG on T1-weighted magnetic resonance imaging (MRIs) showed 18 cases (56.3%) were hyperintense, 1 case (3.13%) was isointense, 4 (12.5%) had mixed-signal intensity, and 2 (6.25%) were hypointense. On T2-weighted MRIs, five lesions (15.6%) were hyperintense, three (9.38%) were isointense, nine (28.1%) were heterogeneous, and nine (28.1%) were hypointense. Only one case (3.1%) had calcifications on computed tomography scan similar to ours. In 14 cases (43.7%), the lesions enhanced with contrast administration on MRI.

Conclusion Prolactinomas with secondary xanthogranulomatous change represent a rare cause of XG of the sella. With no radiological or clinical signs specific for XG of the sellar region, preoperative diagnosis can be challenging, if not impossible.

Keywords

prolactinoma - xanthogranuloma - endoscopic transphenoidal - pituitary adenoma - craniopharyngioma

Notes

This article has not been presented at a conference.

No clinical trial registration number required.

• References

• 1 Paulus W, Honegger J, Keyvani K, Fahlbusch R. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 1999; 97 (04) 377-382
• 2 Kleinschmidt-DeMasters BK, Lillehei KO, Hankinson TC. Review of xanthomatous lesions of the sella. Brain Pathol 2017; 27 (03) 377-395
• 3 Ben Nsir A, Thai QA, Chaieb L, Jemel H. Calcified suprasellar xanthogranuloma presenting with primary amenorrhea in a 17-year-old girl: case report and literature review. World Neurosurg 2015; 84 (03) 866.e11-866 .e14
• 4 Gurcay AG, Gurcan O, Kazanci A. , et al. Xanthogranuloma of the sellar region. Neurol India 2016; 64 (05) 1075-1079
• 5 Stepan KO, Sharma A, Chicoine MR, Uppaluri R, Dahiya S. Juvenile xanthogranuloma of supra-sellar region: a rare presentation. Clin Neuropathol 2015; 34 (06) 368-370
• 6 Rahmani R, Sukumaran M, Donaldson AM, Akselrod O, Lavi E, Schwartz TH. Parasellar xanthogranulomas. J Neurosurg 2015; 122 (04) 812-817
• 7 Nishiuchi T, Murao K, Imachi H. , et al. Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report. J Med Case Reports 2012; 6: 119
• 8 Agarwal A, Agarwal K, Lee HK. Xanthogranuloma of the sellar region. A case report. Neuroradiol J 2012; 25 (02) 181-184
• 9 Kamoshima Y, Sawamura Y, Motegi H, Kubota K, Houkin K. Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) 2011; 51 (10) 689-693
• 10 Miyajima Y, Oka H, Utsuki S, Fujii K. Rathke's cleft cyst with xanthogranulomatous change--case report. Neurol Med Chir (Tokyo) 2011; 51 (10) 740-742
• 11 Nishioka H, Shibuya M, Ohtsuka K, Ikeda Y, Haraoka J. Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction. Neuroradiology 2010; 52 (11) 997-1002
• 12 Sulentić P, Cupić H, Cerina V, Vrkljan M. Xanthogranuloma of the sellar region in a patient with sarcoidosis. Acta Clin Croat 2010; 49 (01) 61-65
• 13 Arai A, Nishihara M, Sasayama T. , et al. Xanthogranuloma of the sellar region--case report. Neurol Med Chir (Tokyo) 2010; 50 (06) 488-491
• 14 Sugata S, Hirano H, Yatsushiro K, Yunoue S, Nakamura K, Arita K. Xanthogranuloma in the suprasellar region. Neurol Med Chir (Tokyo) 2009; 49 (03) 124-127
• 15 Liu ZH, Tzaan WC, Wu YY, Chen HC. Sellar xanthogranuloma manifesting as obstructive hydrocephalus. J Clin Neurosci 2008; 15 (08) 929-933
• 16 Tajima T, Sawamura Y, Ishizu K, Tsubaki J. Two children with xanthogranuloma of the sellar region. Clin Pediatr Endocrinol 2006; 15 (03) 85-91
• 17 Jung CS, Schänzer A, Hattingen E, Plate KH, Seifert V. Xanthogranuloma of the sellar region. Acta Neurochir (Wien) 2006; 148 (04) 473-477
• 18 Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK. Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 2003; 6 (03) 161-168
• 19 Yonezawa K, Shirataki K, Sakagami Y, Kohmura E. Panhypopituitarism induced by cholesterol granuloma in the sellar region--case report. Neurol Med Chir (Tokyo) 2003; 43 (05) 259-262
• 20 Osborn A. Nonastrocytic glial neoplasms. In: Osborn A, ed. Osborn' Brain Imaging, Pathology and Anatomy. Manitoba Canada: Amirsys Publishing Inc; 2013. :510
• 21 Yang B, Yang C, Fang J. , et al. Clinicoradiologic features and surgical outcomes of sellar xanthogranulomas: A single-center 10-year experience. World Neurosurg 2017; 99: 439-447